The well-established link between cancer and tobacco may provide a way to help communicate the links between moderate levels of alcohol and cancer, and raise public awareness of alcohol-associated cancer risks, according to a study published in the open access journal BMC Public Health.
This finding on how cells penetrate tissue gives a boost to the field of metabolomics, which can complement immunotherapies -- using the body's natural defenses to kill cancer cells.
Changing when you eat rather than what you eat may prove to be a dietary intervention against breast cancer, suggests a new mouse study to be presented Saturday at ENDO 2019, the Endocrine Society's annual meeting in New Orleans, La.
A team of McMaster University engineers has found a way to use 3D printing technology to create artificial tumours to help researchers test new drugs and therapies, which could lead to personalized medicine.
New study in mice by University of Illinois researchers finds that the compounds in thermally abused cooking oils may trigger genetic, biochemical changes that hasten the progression of late-stage breast cancer, promoting tumor cells' growth and proliferation.
A researcher in the Vera Bradley Foundation Center for Breast Cancer Research at the Indiana University School of Medicine, working in collaboration with researchers from the University of Maryland, recently reported several important findings related to triple negative breast cancer and its future treatment in the journal Nature Nanotechnology.
State breast density notification laws that mandate reporting of mammogram results can prompt further screening and modestly boost cancer detection rates, say researchers at Yale's School of Public Health and School of Medicine. Their study was published in the American Journal of Public Health.
A novel precision medicine strategy described in Science Advances offers an intriguing ray of hope for triple-negative breast cancer. The proof-of-concept study shows that dually-targeted, antibody-guided nanoparticles, loaded with an existing chemotherapy drug, markedly improved tumor targeting, decreased tumor and metastatic growth and dramatically improved survival in a mouse model -- with no observable side effects.
The use of digital breast tomosynthesis, also known as 3D mammography, may significantly reduce the number of women who undergo breast biopsy for a non-cancerous lesion following an abnormal mammogram, according to a new study.
Fewer women are assigned to a dense breast category when evaluated with advanced mammographic screening technologies compared to standard digital mammography, according to a new study.